Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dimeric opioid antagonists.

C W Thornber1, J S Shaw, L Miller

  • 1Department of Chemistry, ICI Pharmaceuticals Division, Macclesfield, Cheshire, UK.

NIDA Research Monograph
|January 1, 1986
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effect of Baseline Performance and Age on Cognitive Training Improvements in Older Adults: A Qualitative Review.

The journal of prevention of Alzheimer's disease·2020
Same author

F1 hybrid versus 32 selected F7 lines performance of common winter wheat (Triticum aestivum ssp. vulgare).

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Retrieval-induced forgetting in an eyewitness-memory paradigm.

Psychonomic bulletin & review·2013
Same author

Lay Attitudes toward Genetic Testing for Susceptibility to Inherited Diseases.

Journal of health psychology·2011
Same author

Infectious feline agranulocytosis.

The American journal of pathology·2009
Same author

Establishing pragmatic estimated GFR thresholds to guide metformin prescribing.

Diabetic medicine : a journal of the British Diabetic Association·2007
Same journal

EVALUATION OF DRUG ABUSE TREATMENT MEDICATIONS: CONCORDANCE BETWEEN CLINICAL AND PRECLINICAL STUDIES.

NIDA research monograph·2006
Same journal

Problems of drug dependence 1999: Proceedings of the 61st annual scientific meeting, the College on Problems of Drug Dependence, Inc.

NIDA research monograph·2001
Same journal

Problems of drug dependence 1997: proceedings of the 59th annual scientific meeting.

NIDA research monograph·1998
Same journal

Laboratory Behavioral Studies of Vulnerability to Drug Abuse. Proceedings of a meeting. August 2-3, 1994.

NIDA research monograph·1998
Same journal

Disaggregating the liability for drug abuse.

NIDA research monograph·1998
Same journal

Integrating genetic and behavioral models in the study of substance abuse mechanisms.

NIDA research monograph·1998
See all related articles

Dimeric pentapeptide opioid antagonists were tested for their interaction with delta-opioid receptors. The study found no evidence supporting the hypothesis that these antagonists bind to dimeric delta-opioid receptors.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Biochemistry

Background:

  • Opioid receptors are crucial targets for pain management and other therapeutic interventions.
  • The delta-opioid receptor subtype plays a significant role in modulating pain and other physiological processes.
  • Understanding the structural requirements for opioid antagonist binding is essential for developing novel therapeutics.

Purpose of the Study:

  • To investigate the binding characteristics of novel symmetrical and unsymmetrical dimeric pentapeptide opioid antagonists.
  • To test the hypothesis that these dimeric antagonists interact with dimeric delta-opioid receptors.

Main Methods:

  • Preparation of symmetrical and unsymmetrical dimeric pentapeptide opioid antagonists.
  • In vitro pharmacological studies using the mouse vas deferens preparation.

Related Experiment Videos

Main Results:

  • The tested dimeric pentapeptide opioid antagonists did not exhibit binding patterns consistent with dimeric delta-opioid receptors.
  • The experimental data do not support the proposed hypothesis regarding the interaction of these agents with dimeric delta-opioid receptors.

Conclusions:

  • The findings suggest that dimeric delta-opioid receptors may not be the primary binding sites for these specific dimeric pentapeptide opioid antagonists.
  • Further research is needed to elucidate the precise binding mechanisms and receptor interactions of these novel compounds.